Navigation Links
AssureRx Closes Round of Funding to Commercialize Pharmacogenetic Test
Date:3/5/2008

Company commercializes technology from Cincinnati Children's and Mayo

Clinic to help doctors select right drug at right dose for patients

CINCINNATI, March 5 /PRNewswire/ -- AssureRx, a personalized medicine company, today announced that it has closed a round of funding.

The company was founded in 2006 to license and commercialize pharmacogenetic technology from Cincinnati Children's Hospital Medical Center and Mayo Clinic. The technology utilized in the AssureRx non-invasive, pharmacogenetic test measures, analyzes and interprets the genes of patients with common neuro-psychiatric disorders to predict which drugs are best choices for each specific patient. The test helps to take much of the guesswork out of prescribing medications.

"Personalized medicine is the future of health care," said Mark Byrne, chief executive officer of AssureRx. "Our test uses cutting-edge technology to measure, analyze and inform, helping doctors provide customized care based on science. Our comprehensive genetic test, sophisticated interpretive algorithms, quick turnaround and physician-friendly reports provide physicians a unique guide that will save money, save time and save lives."

Pharmacogenetics helps physicians determine how an individual patient will respond to an individual drug, and at what dose. AssureRx analyzes not just one gene, but several genes to predict how patients will respond to medicines. The patent-pending technology takes many genetic variables into consideration and translates the data into a report for doctors within 48 hours of receiving a sample from a patient.

"Until now, doctors have had to determine the safety and effectiveness of psychotropic drug selection and dosing for an individual patient through trial and error," said David Mrazek, M.D., Chair, Mayo Clinic Department of Psychiatry and Psychology. "This technology allows for a personalized patient report based on known science and the specific genetic mak
'/>"/>

SOURCE AssureRx
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related biology technology :

1. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
2. Genmab Discloses Target and Development Plans for HuMax-Inflam
3. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
4. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
5. Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund
6. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
7. BioVex Closes Second Round of Series E Financing
8. Pharmaxis Closes Share Purchase Plan
9. The closest look ever at native human tissue
10. Helix BioPharma closes $16.9 million private placement of common shares
11. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Corporation, an innovator of advanced optical instruments, announced ... with Harvard University granting Nikon the rights to ... Under the terms of the agreement, Nikon will ... with the N-STORM name. ,, Nikon Corporation ...
(Date:12/3/2009)... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... the treatment of cardiovascular and metabolic disease, today announced ... its Phase 2 FDG-PET clinical trial of VIA-2291. ... carried out at five sites in the US and ...
(Date:12/3/2009)... (Nasdaq: PPHM ) today announced that it will release ... 2010 on December 10, 2009 at 7:00 a.m. EST and ... results at 11:30 a.m. EST on the same day. ,, ... quarter ended October 31, 2009 and will review recent operating ...
(Date:12/3/2009)... Inc. (Nasdaq: CALP ), a leading provider of ... research, today introduced Living Image 4.0 software for IVIS® ... more than 800 Caliper IVIS systems currently installed in ... tools to enhance fluorescent sensitivity and automated 3D image ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Caliper Life Sciences Launches Living Image(R) 4.0 Software 2
... year as a contestent, Vector Surgical , an Oconomowoc ... cancer surgery, is the winner of the 2007 Governor's ... the life sciences category, beat out three other category winners ... Entrepreneurs' Conference . The 2007 contest, produced by the ...
... Sometimes, legislators like me can focus too much on the ... of time talking about our oppressive tax burden, out of ... business development and an economy that is growing more slowly ... things require our immediate attention, we should not ignore the ...
... I'm exhausted! I've been running hard up the Vista/Office ... I'm just plain worn out. Productivity is in the basement. ... do is write a column, synchronize my e-mail, launch a ... I've been doing for years. The challenge started when I ...
Other Biology Technology:Surgical products company wins Governor's Business Plan Contest 2Surgical products company wins Governor's Business Plan Contest 3Surgical products company wins Governor's Business Plan Contest 4A heavenly tax cut: Act 255 stimulates economic growth 2A heavenly tax cut: Act 255 stimulates economic growth 3Picking Vista sure seemed like a good idea at the time 2Picking Vista sure seemed like a good idea at the time 3
(Date:12/4/2009)... organs relevant for coronary artery disease (CAD), scientists at ... module of genes that is important for the recruitment ... findings, which are to be published in the open-access ... migration of white blood cells in the development of ...
(Date:12/4/2009)... available in German . , A new ... could help to understand the positive effect of dietary restriction ... and mice) have shown that dietary restriction increases longevity, but ... the female fruit fly reproduces less frequently with a reduced ...
(Date:12/3/2009)... International, Inc. (OTC Bulletin Board: BKYI), a leader ... solutions, announced that a majority of its shareholders ... the sale of the company,s Law Enforcement Division ... voted, 98.6% were cast in favor and 1.2% ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3AARP Commends Legislature For Saving Critical Health Care Program 60438 1Beaumont Weight Control Center Now Offers MicroNutrient Testing 60435 1Beaumont Weight Control Center Now Offers MicroNutrient Testing 60435 2National Council on Agings Firman Lauds CLASS Act as Part of House Health Care Bill 60432 1National Council on Agings Firman Lauds CLASS Act as Part of House Health Care Bill 60432 2National Council on Agings Firman Lauds CLASS Act as Part of House Health Care Bill 60432 3
... their ivory at a pace unseen since an international ban ... public outcry that resulted in that ban is absent today, ... because the public seems to be unaware of the giant ... Africa is about 8 percent a year based on recent ...
... new study by researchers at the National Institute of Environmental ... shows that pregnant women who binge drink early in their ... with oral clefts. , The researchers found that women who ... were more than twice as likely than non-drinkers to have ...
... plants to the lowliest bacterium use molecules to communicate. ... development, and still others are used to attract members ... of Technology have now found a rare kind of ... that serves a dual purpose, working as both ...
Other Biology News:Ivory poaching at critical levels: Elephants on path to extinction by 2020? 2Ivory poaching at critical levels: Elephants on path to extinction by 2020? 3Alcohol binges early in pregnancy increase risk of infant oral clefts 2Caltech researchers find dual-use sexual attraction and population-control chemicals in nematodes 2Caltech researchers find dual-use sexual attraction and population-control chemicals in nematodes 3
... is a compact, highly versatile power supply. Capable ... milliamps, this power supply is ideal for PAGE, ... as all types of small format transfer apparatus. ... or constant current with a continuously variable output ...
... highly compact, extremely reliable and easy to use ... hi-lo range switch control the output, which is ... 250 volts. One two-position switch toggles the bright ... current. For maximum safety, the EC105 is equipped ...
... CC1041 is a recombinant 177 amino ... Gly265 of mature human MT1-MMP. Produced ... of MT1-MMP purified from E. coli periplasm. ... catalytic domain is = 140 mU/mg, where ...
... mM sodium phosphate buffer, pH 6.5. Cathepsin ... a major lysosomal aspartyl protease in mammalian ... Overexpression of cathepsin D in human breast ... relapse and metastasis. Cathepsin D degrades extracellular ...
Biology Products: